NewsStocks GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines by admin 03/07/2024 03/07/2024 Key Takeaways GSK has purchased the rights to COVID-19 and flu vaccines being developed in … 0 FacebookTwitterPinterestEmail